细菌菌体的特征 GEC_vB_Bfr_UZM3 对Bacteroides fragilis具有活性
Nata Bakuradze1,2,3, Maia Merabishvili4, Ia Kusradze5,6
1Laboratory of Microbial Biotechnology, Eliava Institute of Bacteriophages, Microbiology and Virology, Tbilisi 0160, Georgia.
Viruses
|May 27, 2023
概括
菌体为抗生素提供了一个有前途的替代品,用于治疗耐药的 Bacteroides fragilis 感染. 一种新特征的菌体,UZM3,表现出稳定性,缺乏毒性基因,使其成为潜在的治疗候选者.
科学领域:
- 微生物学 微生物学
- 传染性疾病 传染性疾病
- 细菌治疗疗法是一种细菌治疗.
背景情况:
- 一种常见的肠道细菌Bacteroides fragilis越来越多地与难以治疗的血液和组织感染有关.
- 在B. fragilis中出现的抗生素耐药性需要替代治疗策略.
- 菌体 (菌体) 已经证明对抗多药耐药细菌感染的有效性.
研究的目的:
- 鉴定菌体GEC_vB_Bfr_UZM3 (UZM3) 的特征,以对抗B. fragilis感染的潜在治疗用途.
- 评估UZM3.3的生物和基因组特性.
- 评估UZM3适用于治疗由B. fragilis引起的慢性骨髓炎的适用性.
主要方法:
- 分离和表征菌体UZM3.3.
- 评估生物特性,包括在体温和各种pH值水平上的稳定性.
- 全基因组测序UZM3以确定毒性因素.
主要成果:
- 鉴定出UZM3是一种严格的性细菌菌体,是一种细菌菌体的型细菌体.
- 在37°C和生理pH下,UZM3在至少6小时内表现出高稳定性.
- 基因组分析证实UZM3.3中没有已知的毒性基因.
结论:
- 菌体UZM3对治疗B. fragilis的治疗应用具有有利的特性.
- UZM3的溶解性质,稳定性和缺乏毒性基因支持其作为安全有效的治疗选择的潜力.
- UZM3 是一种有希望的菌体治疗候选者,用于治疗耐火性B. fragilis感染.
相关概念视频
DNA Bacteriophages
66
Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
66
Bacterial Phylum Bacteroidota
52
The phylum Bacteroidota includes over 700 species classified into four primary orders: Bacteroidales, Cytophagales, Flavobacteriales, and Sphingobacteriales. These gram-negative, non-sporulating rods exhibit saccharolytic capabilities and can be aerobic or fermentative, encompassing obligate aerobes, facultative aerobes, and obligate anaerobes. Many species display gliding motility, though some are nonmotile or use flagella. The genus Bacteroides is well-studied due to its significant role in...
52
Viral Replication: Lytic Cycle
94
Bacteriophages, or phages, are viruses that specifically infect bacteria. Among them, T-even bacteriophages, such as T4, exhibit a well-characterized lytic replication cycle in Escherichia coli (E. coli). This process ensures the rapid proliferation of the virus while ultimately leading to the destruction of the bacterial host.Attachment and DNA InjectionThe infection process begins with the recognition and binding of the T4 phage to the E. coli cell surface. Tail fibers of the phage...
94
Lytic Cycle of Bacteriophages
71.2K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
71.2K
Bacterial Phylum Verrucomicrobiota
46
The phylum Verrucomicrobiota comprises at least four characterized orders, with most species classified within the order Verrucomicrobiotales. Members of this phylum are either aerobic or facultatively aerobic, with the ability to ferment sugars. A notable exception is the genus Methylacidiphilum, which consists of aerobic methanotrophs. Additionally, some Verrucomicrobiota establish symbiotic relationships with protists. These bacteria are widely distributed across various environments,...
46
Bacterial Phylum Proteobacteria
49
Proteobacteria, one of the largest and most diverse bacterial phyla, encompasses a wide range of Gram-negative bacteria distinguished by their outer membrane composed of lipopolysaccharides. These microorganisms exhibit various metabolic capabilities, including phototrophy, chemolithotrophy, and heterotrophy, and thrive in diverse environments from soil to aquatic systems and host-associated niches. The phylum is divided into six classes: Alphaproteobacteria, Betaproteobacteria,...
49


